Here are relevant reports on : pain-management-market
-
Veterinary Biologics Market by Product (Monoclonal Antibodies, Diagnostic Kits, Immunoglobulins & Antitoxins), RoA (Injectable, Oral), Application (Infectious Disease Prevention, Dermatology, Pain Management), Animal, End User - Global Forecast to 2030
The global veterinary biologics market, valued at US$2.61 billion in 2024, stood at US$2.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2030, culminating in a forecasted valuation of US$3.51 billion by the end of the period. The market growth is fueled by increasing demand for effective animal therapeutics, rising populations of livestock and companion animals, and greater awareness of animal health and disease prevention.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Elastomeric Infusion Pumps Market by Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain Management, Antibiotics), End-use Industry (Hospitals, Ambulatory Surgical Centers, Home-care Settings), and Region - Global Forecast to 2030
The elastomeric infusion pumps market is expected to grow from USD 1.15 billion in 2025 to USD 1.49 billion by 2030, at a CAGR of 5.3% during the forecast period. The report profiles key companies, including Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), and WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain), and DAIKEN MEDICAL CO., LTD. (Japan).
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Electrotherapy Market by Treatment Type (TSE, IC, PSWD, TENS, SCS, EA, PENS), Application (Sports Injury, Tissue Repair, Pain Management), By End User (Hospitals, Clinics, Rehabilitation Centres) - Global Forecast to 2022
The global electrotherapy market is expected to reach $1,076.1 Million by 2022 from $902.5 Million in 2017, growing at a CAGR of 4.0% from 2017 to 2022. Increasing incidences of diabetes; technological advancements in electrotherapy systems; increasing obesity; and rising number of sports injuries are some of the major driving factors driving the growth of the global electrotherapy market. However, lack of awareness about the usage of electrotherapy systems in developing countries; availability of large number of substitutes; and saturation in developed countries are hindering the growth of this market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cryotherapy Market by Product (Cryosurgery Devices, Localized Cryotherapy Devices, Cryosaunas), Application (Surgical Application, Pain Management, Health & Beauty), End User (Hospitals & Specialty Clinics, Spas) - Global Forecast to 2024
The Cryotherapy Market is projected to reach USD 319 million by 2024, at a CAGR of 9.1%. The major players operating in the cryotherapy market include Medtronic (Ireland), Galil Medical (US), and CooperSurgical (US). Other players involved in this market include Impact Cryotherapy (US), Zimmer MedizinSysteme (Germany), Metrum Cryoflex (Poland), Brymill Cryogenic Systems (UK), Erbe Elektromedizin (Germany), CryoConcepts (US), US Cryotherapy (US), Professional Products (US), and Kriosystem Life (Poland).
- Published: July 2019
- Price: $ 4950
- TOC Available:
-
Medical Nitrous Oxide Market by Product (Gas, Liquid), Application (Anesthesia, Pain, Cryosurgery, Surgical Insufflation), End User (Hospital, Home healthcare, Academic, Research Institution), Key Stakeholder & Buying Criteria - Global Forecast to 2029
The global medical nitrous oxide market, valued at US$1.7 billion in 2022, stood at US$1.8 billion in 2023 and is projected to advance at a resilient CAGR of 6.6% from 2023 to 2029, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The market is primarily driven by factors such as an increase in surgical procedures, a growing aging population, advancements in healthcare infrastructure, and growth in the dental industry.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Ablation Technology Market by Technology (RF, Pulse Field, Microwave, Laser, Electrical, Ultrasound, Cryo), Product (Generator, Electrode, Probe), Application (CV, Cancer, Pain, Ortho, Cosmetics), Enduser (Hospital, ASC) & Region Global Forecasts to 2029
The global ablation technology market, valued at US$5.58 billion in 2023, stood at US$6.11 billion in 2024 and is projected to advance at a resilient CAGR of 9.5% from 2024 to 2029, culminating in a forecasted valuation of US$9.62 billion by the end of the period. The drivers for this market include expanding access to healthcare services, an increasing preference for minimally invasive treatments, and the use of ablation procedures in expanded application fields that fuel the ablation technology market growth.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Wearable Healthcare Devices Market by Product (Trackers, Smartwatch, Patches), Type (Diagnostic (Vital Sign, ECG, Glucose), Therapeutic (Pain, Insulin)), Grade (Consumer, Clinical), Channel (Online, Pharmacy), Application (RPM) - Global Forecast to 2030
The global wearable healthcare devices market, valued at US$41.07 billion in 2024, stood at US$45.29 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$75.98 billion by the end of the period. Market growth is driven by rising health awareness, a shift toward preventive care, and the increasing prevalence of chronic conditions in aging populations.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030
The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of US$379.17 billion by the end of the period. The increasing prevalence of chronic diseases worldwide, coupled with the introduction and approval of innovative advanced therapeutics, is driving significant market expansion.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Transdermal Patches Market by Type (Drug-in-adhesives, Matrix, Reservoir Membrane), Adhesive (Acrylic, Silicone, Hydrogel), Application (Pain, CVS, Hormonal), Distribution Channel (Pharmacy (Retail Online, Hospital)), End User & Region - Global Forecast to 2029
The global transdermal patches market, valued at US$5.9 billion in 2022, stood at US$6.2 billion in 2023 and is projected to advance at a resilient CAGR of 4.5% from 2023 to 2029, culminating in a forecasted valuation of US$8.0 billion by the end of the period. over the anticipated term, a number of problems, such as medication failure, transdermal drug delivery system recalls, and growing healthcare facility costs, will probably limit market growth to some degree.
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
Botulinum Toxins Market by Product (Botox, Dysport, Jeuveau, Myobloc), Application (Cosmetic (Wrinkle Removal, Contouring, Skin rejuvenation), Therapeutic (OAB, Migraine, Spasm, Pain)), Volume, End User (Clinics, Center), Region - Global Forecast to 2030
The global botulinum toxins market, valued at US$8.1 billion in 2024, stood at US$8.9 billion in 2025 and is projected to advance at a resilient CAGR of 11.7% from 2025 to 2030, culminating in a forecasted valuation of US$15.7 billion by the end of the period.The rising societal emphasis on maintaining a youthful appearance, especially within urban environments and professional contexts, is driving an increasing number of individuals to seek out cosmetic procedures, with botulinum toxins (commonly known as Botox) being among the most popular options.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
